Chloroquine Elimination in Humans: Effect of Low‐Dose Cimetidine

Abstract

A controlled study was carried out in ten healthy, male volunteers (randomly distributed into control and test groups of five subjects each) to determine the effect of low‐dose cimetidine on chloroquine elimination. The control group subjects received two tablets of chloroquine sulfate (300‐mg base) only, while the test group subjects took 400‐mg cimetidine at bedtime for four days prior to chloroquine (two tablets of chloroquine sulfate) administration and throughout the duration of the study. Blood samples, 5 mL, were collected periodically after chloroquine administration. The samples were assayed for chloroquine and monodesethylchloroquine using a combination of thin‐layer chromatography and spectrophotometry. Wilcoxon's test for unpaired data at P < .05 was used to determine if there was any significant difference in the elimination of chloroquine in the test group when compared with the control group. The apparent oral clearance rate of chloroquine was reduced from 0.49 ± 0.04 L/d/kg in the control group to 0.23 ± 0.02 L/d/kg in the test group, and the elimination half‐life was prolonged from 3.11 days in the control group to 4.62 days in the test group. There was a 47.04% reduction in the AUC_0‐7d of monodesethylchloroquine, the major metabolite of chloroquine, in the test group when compared with the control group. The apparent volume of distribution at steady state was increased from 0.46 ± 0.07 L/kg in the control group to 0.72 ± 0.10 L/kg in the test group. All these changes were statistically significant. The conclusion is that cimetidine impairs the elimination of chloroquine in healthy subjects.